Friday, June 27, 2025 6/27/2025

TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS

Award Number: R44DK066955
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 08/01/2004
PERIOD OF PERFORMANCE END DATE: 07/31/2007

Group Awards By:

View Award Description

TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS - DESCRIPTION (provided by applicant): SBIR Phase I Research: This proposal aims to examine the predictive utility of an in vivo primate toxicogenomic model of human hepatotoxicity. Hepatotoxicity is the most significant and common adverse drug reaction. A central challenge to pharmaceutical drug development therefore is the early identification and elimination of drug candidates with unfavorable liver toxicity profiles. The ability to employ microarrays to measure global gene expression patterns that precede biochemical and pathologic change has contributed to the emergence of toxicogenomics as a promising method of rapidly assessing potential toxicity. As with conventional toxicity assays, however, interspecies biological differences may pose a significant limitation to predictive toxicogenomics. Due to genomic and physiologic similarities, toxicogenomic studies in nonhuman primates may improve the relevance to human toxicity and associated molecular mechanisms. The proposed studies test the hypotheses that transcriptional changes can be detected in primate hepatic tissue in vivo that are predictive of primate hepatotoxicity, and hence human hepatotoxicity, and that these transcriptional changes are reflective of the severity of conventional biochemical and pathological toxicity measures in a dose dependant manner. Changes in gene expression in liver tissue, liver pathology and serum ALT, LDH, bilirubin, prothrombin time and glucose will be assessed at multiple time points following acute administration of acetaminophen, a widely used analgesic with intrinsic hepatotoxicity. This will allow a determination of the sequence of transcriptional changes that parallel or proceed histologic and biochemical events. Transcriptional changes induced by an established hepatotoxic dose of acetaminophen will be evaluated, as well as changes induced by two lower doses, the lower of which is estimated not to be hepatotoxic. The resulting dose response data will allow the identification of transcriptional profiles that are associated with acetaminophen toxicity and distinguishable from other biological effects. Defining the chronologic and dose dependent gene expression changes induced by acetaminophen may reveal a unique early transcriptional profile that is predictive of hepatic injury from this widely used medication, providing support for the utility of primate based toxicogenomics. Sharing of tissue, blood, and urine samples and data with FDA and NIEHS collaborators will allow comparisons with their parallel rodent data and add complementary data on accessible biomarkers and metabonomics.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2006 ( Subtotal = $791,277 )
2006	2006	RX GEN INC	100 DEEPWOOD DRIVE	HAMDEN	CT	06517	SOUTH CENTRAL CT	USA	Digestive Diseases and Nutrition Research	001	3	7/28/2006	SUPPLEMENT FOR EXPANSION	$55,000
2006	2006	RX GEN INC	100 DEEPWOOD DRIVE	HAMDEN	CT	06517	SOUTH CENTRAL CT	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	7/24/2006	NON-COMPETING CONTINUATION	$736,277
														Subtotal = $791,277

Issue Date FY: 2005 ( Subtotal = $512,528 )
2005	2005	RX GEN INC	100 DEEPWOOD DRIVE	HAMDEN	CT	06517	SOUTH CENTRAL CT	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	9/23/2005	EXTENSION WITH OR WITHOUT FUNDS	$512,528
														Subtotal = $512,528

Issue Date FY: 2004 ( Subtotal = $249,123 )
2004	2004	RX GEN INC	100 DEEPWOOD DRIVE	HAMDEN	CT	06517	SOUTH CENTRAL CT	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	8/12/2004	NEW	$249,123
														Subtotal = $249,123

Grand Total All Awards = $1,552,928

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS

Award Number: R44DK066955

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 08/01/2004

PERIOD OF PERFORMANCE END DATE: 07/31/2007

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer